CRH Medical Corp (TSE:CRH) Director Ian A. Webb sold 7,500 shares of CRH Medical stock in a transaction on Tuesday, June 12th. The shares were sold at an average price of C$4.51, for a total transaction of C$33,825.00.

Shares of CRH Medical traded down C$0.05, reaching C$4.63, during trading hours on Thursday, reports. The company’s stock had a trading volume of 118,454 shares, compared to its average volume of 225,989. CRH Medical Corp has a one year low of C$1.86 and a one year high of C$8.00.

CRH Medical (TSE:CRH) last posted its earnings results on Monday, April 30th. The company reported C$0.03 earnings per share for the quarter, topping analysts’ consensus estimates of C($0.01) by C$0.04. CRH Medical had a net margin of 14.77% and a return on equity of 13.79%. The firm had revenue of C$31.18 million for the quarter, compared to the consensus estimate of C$28.20 million.

A number of brokerages have issued reports on CRH. National Bank Financial lifted their price target on shares of CRH Medical from C$4.25 to C$4.50 and gave the company an “outperform” rating in a report on Tuesday, March 6th. TD Securities boosted their target price on shares of CRH Medical from C$2.50 to C$3.50 and gave the stock a “hold” rating in a report on Wednesday, March 7th. Finally, Royal Bank of Canada boosted their target price on shares of CRH Medical from C$4.50 to C$4.75 and gave the stock an “outperform” rating in a report on Wednesday, May 2nd. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. CRH Medical has an average rating of “Buy” and an average price target of C$4.50.

About CRH Medical

CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with's FREE daily email newsletter.